Silence Therapeutics (LON:SLN) Shares Cross Below Two Hundred Day Moving Average of $535.00

Silence Therapeutics plc (LON:SLNGet Free Report) crossed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of GBX 535 ($6.80) and traded as low as GBX 512 ($6.51). Silence Therapeutics shares last traded at GBX 535 ($6.80), with a volume of 913,528 shares.

Silence Therapeutics Stock Down 0.9 %

The stock has a market capitalization of £480.35 million and a price-to-earnings ratio of -11.01. The company has a debt-to-equity ratio of 0.80, a quick ratio of 4.36 and a current ratio of 4.52. The firm’s fifty day simple moving average is GBX 535 and its 200 day simple moving average is GBX 535.

About Silence Therapeutics

(Get Free Report)

Silence Therapeutics plc, a biotechnology company, focuses on the discovery and development of novel ribonucleic acid (RNA) therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company's platform includes mRNAi GalNAc Oligonucleotide Discovery platform designed to accurately target specific disease-associated genes in the liver.

Read More

Receive News & Ratings for Silence Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Silence Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.